![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Gastrointestinal Stromal Tumors - 30 Studies Found
Recruiting |
: Study of Tumor Samples in Patients Undergoing Treatment for Gastrointestinal Stromal Tumors on Clinical Trial ACOSOG-Z9001 : Gastrointestinal Stromal Tumor : 2009-08-06 :
|
Terminated |
: Imatinib Mesylate and Sunitinib in Treating Patients With Gastrointestinal Stromal Tumors : Gastrointestinal Stromal Tumor : 2007-12-13 :
|
Completed |
: S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors : Gastrointestinal Stromal Tumor : 2000-05-02 : Drug: temozolomide 200 mg/m^2/day, PO, on Days 1-5 of each 28 day cycle. |
Completed |
: Imatinib Mesylate in Treating Patients With Locally Advanced Gastrointestinal Stromal Tumor : Gastrointestinal Stromal Tumor : 2005-06-02 :
|
Active, not recruiting |
: Dasatinib as First-Line Therapy in Treating Patients With Gastrointestinal Stromal Tumors : Gastrointestinal Stromal Tumor : 2007-12-05 : Drug: dasatinib Dasatinib is given orally 70 mg BID. Dasatinib will be continued until progression, unac |
Terminated |
: Imatinib Mesylate With or Without Surgery in Treating Patients With Metastatic Gastrointestinal Stromal Tumor That is Responding to Imatinib Mesylate : Gastrointestinal Stromal Tumor : 2009-08-08 :
|
Terminated |
: Imatinib Mesylate in Treating Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumor : Gastrointestinal Stromal Tumor : 2008-05-22 : Drug: imatinib mesylate By mouth |
Terminated |
: Imatinib Mesylate or Observation Only in Treating Patients Who Have Undergone Surgery for Localized Gastrointestinal Stromal Tumor : Gastrointestinal Stromal Tumor : 2005-02-07 :
|
Active, not recruiting |
: A Study of Famitinib in Patients With Gastrointestinal Stromal Tumor : Gastrointestinal Stromal Tumor : 2015-01-08 : Drug: Famitinib |
Completed |
: Open-label Trial of GlivecWith Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumors : Gastrointestinal Stromal Tumors : 2006-02-16 : Drug: Glivec 400mg p.o./day in a population of patients with locally advanced (=not amenable to surgery |